07.00.14h, Low-Level Laser Therapy
Summary
Independence Blue Cross reissued Policy 07.00.14h on 10/29/2025 to communicate its continuing position on Low-Level Laser Therapy (LLLT). The policy covers LLLT only for prevention of oral mucositis in cancer patients undergoing chemotherapy, radiotherapy, or stem cell transplant; all other uses remain experimental/investigational and non-covered. CPT code 97037 was added to the experimental/investigational category effective 01/02/2024, and billing teams must not misrepresent LLLT services using incorrect codes like 97026.
Get alerts when payers change rules like this one
We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.